Bedside Spirometry for Acute Lung Injury

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Departemental Vendee

About this trial

The diagnosis of Acute Respiratory Distress Syndrome (ARDS) is a syndromic diagnosis that groups together patients who may have very different prognoses and respond differently to the same therapies.

Additionally, non-invasive ventilation (NIV) has shown highly contrasting results in the early management of ARDS. One of the predictive criteria for NIV failure is an excessively high tidal volume during non-invasive ventilation.

SPIRALI is a pilot study evaluating the relevance of a respiratory physiology parameter, the tidal volume relative to the theoretical ideal body weigh, in the phenotypic classification of non-intubated ARDS patients. In this initial approach, the investigators will compare the tidal volume during high-flow oxygen therapy with the tidal volume obtained under NIV (after applying a settings optimization algorithm). The investigators hypothesize that if tidal volume is linked to each situation, the same patients will exhibit a high tidal volume both during spontaneous ventilation and under NIV.

Eligibility criteria

Qualifiers

Patient over 18 years of age;

Patient hospitalized in intensive care for less than 24 hours;

Patient with severe hypoxemic acute respiratory failure characterized by a PaO2/FiO2 ratio < 300 mmHg and > 150 mmHg under high-flow oxygen therapy at 60 L/min;

Patient able to cooperate with the spirometry test;

Disqualifiers

Patients with an indication for intubation;

Patients with a contraindication for or who refuse NIV;

Patients with hemodynamic instability requiring vasopressor support greater than 0.25 μg/kg/min of norepinephrine;

Patients with a Glasgow score < 15;

Trial design

Treatments tested in this trial

  • Hand-held spirometer
  • NIV

Treatment groups

30 Participants
are divided into 1 treatment group